Related Experiment Video
Updated: Feb 18, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric
Hu YiRen1, Yu YingCong2,3, You Sunwu1
1Department of General Surgery, The third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.
Background:
Chemoresistance has long been recognized as a major obstacle in cancer therapy. Clarifying the underlying mechanism of chemoresistance would result in novel strategies to improve patient's response to chemotherapeutics.
Methods:
lncRNA expression levels in gastric cancer (GC) cells was detected by quantitative real-time PCR (qPCR). MALAT1 shRNAs and overexpression vector were transfected into GC cells to down-regulate or up-regulate MALAT1 expression. In vitro and in vivo assays were performed to investigate the functional role of MALAT1 in autophagy associated chemoresistance.
Results:
We showed that chemoresistant GC cells had higher levels of MALAT1 and increased autophagy compared with parental cells. Silencing of MALAT1 inhibited chemo-induced autophagy, whereas MALAT1 promoted autophagy in gastric cancer cells. Knockdown of MALAT1 sensitized GC cells to chemotherapeutics. MALAT1 acts as a competing endogenous RNA for miR-23b-3p and attenuates the inhibitory effect of miR-23b-3p on ATG12, leading to chemo-induced autophagy and chemoresistance in GC cells.
Conclusions:
Taken together, our study revealed a novel mechanism of lncRNA-regulated autophagy-related chemoresistance in GC, casting new lights on the understanding of chemoresistance.
Insights
This study reveals that higher levels of MALAT1 in gastric cancer cells promote chemoresistance by increasing autophagy. Silencing MALAT1 sensitizes cancer cells to chemotherapy, offering new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chemoresistance is a significant challenge in cancer treatment.
- Understanding chemoresistance mechanisms is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of MALAT1 in chemoresistance in gastric cancer.
- To elucidate the mechanism by which MALAT1 influences autophagy and chemoresistance.
Main Methods:
- Quantitative real-time PCR (qPCR) to measure lncRNA expression.
- Transfection of MALAT1 shRNAs and overexpression vectors in gastric cancer cells.
- In vitro and in vivo assays to assess the functional role of MALAT1.
Main Results:
- Chemoresistant gastric cancer cells exhibit elevated MALAT1 levels and increased autophagy.
- MALAT1 knockdown reduces chemo-induced autophagy and sensitizes cells to chemotherapy.
- MALAT1 functions as a competing endogenous RNA for miR-23b-3p, impacting ATG12 expression and promoting autophagy.
Conclusions:
- A novel mechanism of long noncoding RNA (lncRNA)-regulated autophagy-related chemoresistance in gastric cancer was identified.
- MALAT1 plays a key role in mediating chemoresistance through autophagy modulation.
- This finding provides new insights into overcoming chemoresistance in gastric cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
